The Patent Finder
US

Systems and Methods for the Conditioning of Cerebrospinal Fluid

US 11,577,060 In force
OverviewFamilyAssignmentsSources & methods

Term ends Apr 14, 2038 · High confidence

Filed Jan 14, 2020 as application 16/742,870 · Granted Feb 14, 2023
Base term plus 498 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2016 2038
Clock starts
Dec 2, 2016
Term ends
Apr 14, 2038
Granted
Feb 14, 2023
base term patent term adjustment fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
498
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,695,545, to Apr 14, 2038. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 498 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 2, 2016, when application 15/367,592, the earliest non-provisional in its chain, was filed (this one was filed Jan 14, 2020)Dec 2, 2036High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+498 days, USPTO patent term adjustment recordApr 14, 2038High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,695,545)resolves to Apr 14, 2038, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderApr 14, 2038High confidence

This family

US 10,695,545In force
May 2038
May 2038
US 11,577,060this patent
Apr 2038
Apr 2038
US 12,576,251In force
Jul 2038
Jul 2038
Application 19/560,265Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 4, 2021
Reel 54795, frame 607
Minnetronix Medical, Inc.; Minnetronix Neuro, Inc.First Horizon Bank, As Administrative AgentSecurity Interest
Mar 13, 2025
Reel 73460, frame 969
First Horizon BankTexas Capital Bank, As Successor AgentAssignment of Security Interest in Patent Collateral Recorded on Reel 054795 Frame 0607 and Supplemental Patent Security Agreement Recorded on Reel 056240 Frame 0147
Jun 10, 2025
Reel 71588, frame 15
Texas Capital Bank, As Administrative AgentMinnetronix, Inc.; Minnetronix Neuro, Inc. (F/K/A Neurofluidics, Inc.)Partial Release of Patent Security Agreement - Reel 054795 Frame 0607; and Reel 056240 Frame 0147
Jun 10, 2025
reel/frame not recorded
Texas Capital Bank, As Administrative AgentMinnetronix, Inc.Partial Release of Patent Security Agreement - Reel 054795 Frame 0607; and Reel 056240 Frame 0147
Jun 10, 2025
reel/frame not recorded
Texas Capital Bank, As Administrative AgentMinnetronix Neuro, Inc. (F/K/A Neurofluidics, Inc.)Partial Release of Patent Security Agreement - Reel 054795 Frame 0607; and Reel 056240 Frame 0147
Jul 2, 2025
Reel 71588, frame 980
Minnetronix, Inc.Minnetronix Neuro, Inc.Assignment of Assignor's Interest
Oct 1, 2025
Reel 73434, frame 838
Texas Capital Bank, As AgentMinnetronix Medical, Inc.Release of Patent Security Agreement - Reel/Frame 054795/0607, Supplemental Patent Security Agreement - Real/Frame 056240/0147 and Assignment Id: 885388
Oct 29, 2025
Reel 73429, frame 607
Minnetronix Neuro, Inc.Pharaoh Neuro, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited